Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01944332 · ClinicalTrials.gov registry record · NA

Gamete Treatment to Correct Fertilization Failure

A NA study of Infertility, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
1,200
Enrollment target
1
Study location

NCT01944332 is a NA study of Infertility that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 1,200 participants, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01944332, a NA study of Infertility, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
1
Study location

Study Summary

In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

Conditions Studied

Interventions

  • PROCEDURE gamete treatment

Study Locations (1)

New York

  • Center fo Reproductive Medicine - New York

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2007-09
Est. Completion 2027-11-30
Phase NA

What the Registry Record Tells You About NCT01944332

The ClinicalTrials.gov registry entry for NCT01944332 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which gamete treatment is the first listed.

NCT01944332 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01944332 about?

NCT01944332 is a clinical study titled "Gamete Treatment to Correct Fertilization Failure". In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

What is the current status of trial NCT01944332?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2007-09. Estimated completion is 2027-11-30.

What conditions does trial NCT01944332 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT01944332?

The interventions under investigation include: gamete treatment (PROCEDURE).

Who is sponsoring clinical trial NCT01944332?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01944332 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.